Hsu Raymond K, Chai Boyang, Roy Jason A, Anderson Amanda H, Bansal Nisha, Feldman Harold I, Go Alan S, He Jiang, Horwitz Edward J, Kusek John W, Lash James P, Ojo Akinlolu, Sondheimer James H, Townsend Raymond R, Zhan Min, Hsu Chi-Yuan
University of California, San Francisco, San Francisco, CA.
University of Pennsylvania, Philadelphia, PA.
Am J Kidney Dis. 2016 Aug;68(2):193-202. doi: 10.1053/j.ajkd.2015.12.025. Epub 2016 Jan 29.
It is not clear whether the pattern of kidney function decline in patients with chronic kidney disease (CKD) may relate to outcomes after reaching end-stage renal disease (ESRD). We hypothesize that an abrupt decline in kidney function prior to ESRD predicts early death after initiating maintenance hemodialysis therapy.
Prospective cohort study.
SETTING & PARTICIPANTS: The Chronic Renal Insufficiency Cohort (CRIC) Study enrolled men and women with mild to moderate CKD. For this study, we studied 661 individuals who developed chronic kidney failure that required hemodialysis therapy initiation.
The primary predictor was the presence of an abrupt decline in kidney function prior to ESRD. We incorporated annual estimated glomerular filtration rates (eGFRs) into a mixed-effects model to estimate patient-specific eGFRs at 3 months prior to initiation of hemodialysis therapy. Abrupt decline was defined as having an extrapolated eGFR≥30mL/min/1.73m(2) at that time point.
All-cause mortality within 1 year after initiating hemodialysis therapy.
Multivariable Cox proportional hazards.
Among 661 patients with CKD initiating hemodialysis therapy, 56 (8.5%) had an abrupt predialysis decline in kidney function and 69 died within 1 year after initiating hemodialysis therapy. After adjustment for demographics, cardiovascular disease, diabetes, and cancer, abrupt decline in kidney function was associated with a 3-fold higher risk for death within the first year of ESRD (adjusted HR, 3.09; 95% CI, 1.65-5.76).
Relatively small number of outcomes; infrequent (yearly) eGFR determinations; lack of more granular clinical data.
Abrupt decline in kidney function prior to ESRD occurred in a significant minority of incident hemodialysis patients and predicted early death in ESRD.
慢性肾脏病(CKD)患者肾功能下降的模式是否与终末期肾病(ESRD)后的结局相关尚不清楚。我们假设ESRD前肾功能的突然下降预示着开始维持性血液透析治疗后的早期死亡。
前瞻性队列研究。
慢性肾功能不全队列(CRIC)研究纳入了轻度至中度CKD的男性和女性。在本研究中,我们研究了661例发展为需要开始血液透析治疗的慢性肾衰竭患者。
主要预测因素是ESRD前肾功能的突然下降。我们将年度估计肾小球滤过率(eGFR)纳入混合效应模型,以估计血液透析治疗开始前3个月患者特异性的eGFR。突然下降定义为该时间点外推的eGFR≥30mL/min/1.73m²。
开始血液透析治疗后1年内的全因死亡率。
多变量Cox比例风险模型。
在661例开始血液透析治疗的CKD患者中,56例(8.5%)透析前肾功能突然下降,69例在开始血液透析治疗后1年内死亡。在调整了人口统计学、心血管疾病、糖尿病和癌症因素后,肾功能突然下降与ESRD第一年死亡风险高3倍相关(校正后风险比,3.09;95%置信区间,1.65 - 5.76)。
结局数量相对较少;eGFR测定不频繁(每年一次);缺乏更详细的临床数据。
ESRD前肾功能突然下降发生在少数新发血液透析患者中,并预示着ESRD患者的早期死亡。